Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002572658 | SCV002932714 | likely benign | not provided | 2022-02-28 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004529152 | SCV004104374 | uncertain significance | LEPR-related disorder | 2024-04-05 | no assertion criteria provided | clinical testing | The LEPR c.575A>C variant is predicted to result in the amino acid substitution p.Glu192Ala. This variant was observed in a cohort of individuals with obesity, and in vitro functional studies showed this variant did not reduce protein function and could cause increased function (Supplemental Data Set 3, Shah et al. 2023. PubMed ID: 36864747). This variant is reported in 0.036% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |